Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

Telephone and Web-based Teen Tobacco Cessation in HMOs (QWIThelper)

27 septembre 2012 mis à jour par: Kaiser Permanente
The purpose of this study is to look at both the clinicians' ability to reach out to the teen smokers and to evaluate the efficacy of providing tobacco cessation support using a proactive telephone quitline combined with an interactive Web-based program for teens within a managed care environment.

Aperçu de l'étude

Description détaillée

Health maintenance organizations have the mission, incentive, communication tools, and credibility with patients to reach out to teen members who use tobacco. The overall aim of this project is to refine and test both the potential reach and the efficacy of tobacco cessation support using a proactive telephone quitline combined with an interactive Web-based program for teens within a managed care environment. As part of a clinician-directed outreach effort, we will work closely with pediatric clinicians to maximize the program's reach into the teen smoker population as identified through the electronic data base of a large HMO. We will use letters and proactive outreach calls to assess current smoking status and recruit 600 15- to 18-year-old teen smokers who are interested in quitting and would be willing to receive cessation support via telephone and the Web. A second aim will be to randomly assign interested teen smokers to receive a proactive telephone- and Web-based tobacco cessation program or access to a website with cessation materials (control condition) to test the efficacy of the program on long-term cessation rates at 6- and 12-months. We will use several process measures to assess our ability to implement and consistently deliver both the telephone and Web components of the intervention. We will measure mediating variables to determine they support the hypothesized linkages between the theoretical constructs described by our cognitive behavioral model of action. An effective managed care partnership with clinicians to assess, recruit, and intervene with teen smokers would be of great interest to clinicians and health plan managers, highly exportable, and would be given high priority for implementation at the population level.

Our specific aims are as follows:

  1. Compare the population-based recruitment yields and costs of three proactive outreach approaches: 1) outreach calls only to those teen smokers who are seen, advised, and referred to us by their clinician; 2) outreach calls to a random sample of teens shown as being smokers in the EMR; and 3) outreach calls to a sample of all teens
  2. Assess efficacy/effectiveness in a randomized trial with 600 teen smokers to evaluate the hypothesis that proactive telephone-based counseling integrated with an interactive website will increase 6- and 12-month abstinence rates (30-day point prevalence) relative to a control condition receiving mailed cessation materials alone
  3. Assess the hypothesis that the telephone and web-based intervention will improve longer-term maintenance of abstinence at an 12-month follow-up point compared to the control condition
  4. Describe use patterns for key intervention process measures (e.g., calls completed, use of website) and determine if intervention affects outcome through theoretical mediators (e.g., pros/cons, stage, efficacy)
  5. Determine the total costs of the telephone and web-based program from the perspective of the HMO and replication costs in other settings, and report costs as incremental costs per member per month, per program participant, and per quit.

Type d'étude

Interventionnel

Inscription (Réel)

600

Phase

  • Phase 3

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Lieux d'étude

    • Oregon
      • Eugene, Oregon, États-Unis, 97403
        • Oregon Research Institute
      • Portland, Oregon, États-Unis, 97227
        • Kaiser Permanente Center for Health Research
    • Washington
      • Seattle, Washington, États-Unis, 98104
        • Free & Clear, Inc.

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

15 ans à 18 ans (Enfant, Adulte)

Accepte les volontaires sains

Non

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • 15-18 years old
  • both males and females
  • smoking cigarettes at least four days a month
  • some interest in quitting (will take all teen regardless of stage of readiness
  • no evidence of treatment for depression, alcohol, or drugs in last year
  • must consent
  • have physician's approval for outreach to their panel
  • have (or able to get) Internet access and phone access
  • willingness to participate in study and follow-up procedures.

Exclusion Criteria:

  • <15 years old
  • >18 years old
  • treated within 1 year for depression, alcohol, or drugs
  • No internet access or phone access

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Telephone counseling + interactive website
Teen has access to interactive website and receives tailored telephone counseling
Autre: Control with interactive website
Teen only has access to interactive website.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Participants' self-report of smoking one or more cigarettes in the past month at the 6-month and 12-month follow-up.
Délai: 6 months and 12 months
self report of smoking in last 30 days
6 months and 12 months
12-month measure to determine long-term assessment
Délai: 12-months
Self report smoking or not smoking.
12-months

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
A six-month assessment to determine short-term effects
Délai: 6 months
6 months
Assess the prevalence of smoking on 25 or more days per month
Délai: 1 month
1 month
Assess sustained abstinence (e.g., three and six months) at each follow-up,
Délai: 3 months and 6 months
No smoking - yes or no at 3 month timeframe and 6 months timeframe
3 months and 6 months
Assess change in stage of change
Délai: 6 months and 12 months
6 months and 12 months
Assess amount smoked, and use of other tobacco products (including smokeless tobacco) in the last week, 30 days, three months, and six months prior to the follow-up assessment.
Délai: 30 days, 6 months, 12 months
30 days, 6 months, 12 months
Measure the proportion of teen smokers who are recruited through direct physician referral versus proactive outreach
Délai: 1 day
1 day
Compare the population-based recruitment yields and costs of three proactive outreach approaches that health plans might implement
Délai: 12 months
12 months

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Les enquêteurs

  • Chercheur principal: Jack F Hollis, Ph.D., Kaiser Permanente

Publications et liens utiles

La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.

Publications générales

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude

1 mars 2006

Achèvement primaire (Réel)

1 avril 2010

Achèvement de l'étude (Réel)

1 avril 2010

Dates d'inscription aux études

Première soumission

4 avril 2006

Première soumission répondant aux critères de contrôle qualité

4 avril 2006

Première publication (Estimation)

6 avril 2006

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Estimation)

28 septembre 2012

Dernière mise à jour soumise répondant aux critères de contrôle qualité

27 septembre 2012

Dernière vérification

1 septembre 2006

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • 5R01CA098685-02 (Subvention/contrat des NIH des États-Unis)
  • 1R01CA098685-01A2 (Subvention/contrat des NIH des États-Unis)

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

3
S'abonner